% | $
Quotes you view appear here for quick access.

Northwest Biotherapeutics, Inc. Message Board

  • staccani staccani Jan 25, 2014 3:47 AM Flag

    Why would the CEO give out part of the company in exchange of mfg capacity?

    The only answer I have is because that mfg capacity is needed. You do not invest in mfg capacity unless you know that you will need to mass produce! If I were uncertain about it I would have signed a LOI or an agreement subordinated to events such as positive interim test results etc etc. That does not seem to be the case. To me this is a clear sign that tests are going well and that they are quickly getting ready to mass produce.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I guess one of the possibilities is early termination for strong efficacy... in that case the quick ramp up of mfg capacity would make sense ... opinions?

      • 1 Reply to staccani
      • I agree as 8K included both DCVax-L and DCVax-Direct immediate increase in manufacturing in US, UK & Germany as well as Israel where compassionate use has been taken place since 2007. The pre-market Monday morning could be a sign of DMC update on the GBM trial.

        Together, these Agreements provide for substantial expansion of manufacturing capacity for the Company’s programs, in multiple regions, as well as development of the necessary systems and logistics, and other near-term and long-term preparations, for large scale scale-up of the Company’s programs.

        Sentiment: Strong Buy

4.700.00(0.00%)Nov 27 1:00 PMEST